Registry Study for Radiation Therapy Outcomes
Sponsor
Proton Collaborative Group (Other)
Overall Status
Recruiting
CT.gov ID
NCT01255748
Collaborator
(none)
40,000
19
2105.3
Study Details
Study Description
Brief Summary
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
40000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
Study Start Date
:
Jun 1, 2009
Anticipated Primary Completion Date
:
Jun 1, 2039
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Treatment with Radiation Therapy Includes 16 different arms to capture patient data by disease site |
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking
|
Outcome Measures
Primary Outcome Measures
- Define outcomes for patients treated at participating institutions [PRN]
Secondary Outcome Measures
- Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [Annually PRN]
- Improve patient care by an adequate understanding of the results and patient population at participating institutions [Reviewed Annually PRN]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Planned treatment with radiation therapy
-
Ability to understand and sign IRB approved consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Proton International at University of Alabama at Birmingham | Birmingham | Alabama | United States | 35233 |
2 | Mayo Clinic | Scottsdale | Arizona | United States | 85259-5499 |
3 | California Protons Cancer Therapy Center | San Diego | California | United States | 92121 |
4 | Miami Cancer Institute | Miami | Florida | United States | 33176 |
5 | Orlando Health Cancer Institute | Orlando | Florida | United States | 32806 |
6 | Emory Proton Therapy Center | Atlanta | Georgia | United States | 30308 |
7 | Northwestern Medicine Chicago Proton Center | Warrenville | Illinois | United States | 60555 |
8 | University of Kansas Proton Therapy Center | Kansas City | Kansas | United States | 66160 |
9 | Willis-Knighton Cancer and Proton Therapy Center | Shreveport | Louisiana | United States | 71103 |
10 | Maryland Proton Treatment Center | Baltimore | Maryland | United States | 21201 |
11 | McLaren Proton Therapy Center | Flint | Michigan | United States | 48532 |
12 | ProCure Proton Therapy Center | Somerset | New Jersey | United States | 08873 |
13 | New York Proton Center | New York | New York | United States | 10035 |
14 | University of Cincinnati Medical Center | Cincinnati | Ohio | United States | 45044 |
15 | Oklahoma Proton Center | Oklahoma City | Oklahoma | United States | 73142 |
16 | Thompson Proton Center | Knoxville | Tennessee | United States | 37909 |
17 | Inova Schar Cancer Institute | Fairfax | Virginia | United States | 22031 |
18 | Hampton University Proton Therapy Institute | Hampton | Virginia | United States | 23666 |
19 | University of Washington | Seattle | Washington | United States | 98195-6043 |
Sponsors and Collaborators
- Proton Collaborative Group
Investigators
- Study Chair: Carlos Vargas, MD, Proton Collaborative Group
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Proton Collaborative Group
ClinicalTrials.gov Identifier:
NCT01255748
Other Study ID Numbers:
- REG001-09
First Posted:
Dec 7, 2010
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2022
Keywords provided by Proton Collaborative Group